Identification of PMN-released mutagenic factors in a co-culture model for colitis-associated cancer. (2nd November 2017)

• Record Type: Journal Article
• Authors: Granofszky, Nicolas; Lang, Michaela; Khare, Vineeta; Schmid, Gerald; Scharl, Theresa; Ferk, Franziska; Jimenez, Kristine; Knasmüller, Siegfried; Campregher, Christoph; Gasche, Christoph
• Is Part Of: Carcinogenesis. Volume 39:Number 2(2018)
• Page Start: 146
• Page End: 157
• Publication Date: 2017-11-02
• Subjects: Carcinogenesis -- Periodicals; Cancer -- Genetic aspects -- Periodicals; Cancer -- Prevention -- Periodicals; Cancer -- Periodicals; 616.994071
• DOI: 10.1093/carcin/bgx118
• Languages: English
• ISSNs: 0143-3334

Abstract

Abstract : Polymorphonuclear cells release various factors which may induce microsatellite instability (MSI) in colon epithelial cells. H202 and certain cytokines produced by PMNs increased MSI and intracellular ROS. JAK inhibiton abrogated MSI. Our data add to the knowledge of mutagenesis in colitis-associated colorectal cancer. Abstract: Microsatellite instability (MSI) is present in ulcerative colitis (UC) and colitis-associated colorectal cancers (CAC). Certain factors released by polymorphonuclear cells (PMNs) may drive mucosal frameshift mutations resulting in MSI and cancer. Here, we applied a co-culture system with PMNs and colon epithelial cells to identify such culprit factors. Subjecting HCT116 + chr3 and human colonic epithelial cells (HCEC)-1CT MSI-reporter cell lines harboring mono-, di- or tetranucleotide DNA repeats linked to enhanced green fluorescent protein (EGFP) to activated PMNs induced frameshift mutations within all repeats, as quantified by flow cytometry. Activated PMNs released superoxide and hydrogen peroxide (H2 O2 ), as measured by lucigenin-amplified chemiluminescence and fluorometry, respectively. Catalase, which scavenges H2 O2, reduced such PMN-induced MSI. The NADPH-oxidase inhibitor apocynin, which blocks the oxidative burst in PMNs, similarly inhibited PMN-induced MSI. A bead-based multiplex assay revealed that PMNs release a wide range of cytokines such as interleukin (IL)-8, IL-6 and tumor necrosis factor-α (TNF-α). In vitro, these cytokines increased MSI in colon epithelial cells, and the Janus kinase (JAK) inhibitor tofacitinib abolished IL-6-induced or PMN-induced MSI. Intracellular reactive oxygen species (ROS) formation, as measured by 2', 7'–dichlorofluorescein diacetate (DCFDA) assay, was induced upon cytokine treatment. DNA oxidation upon IL-6 was present, as detected by formamidopyrimidine glycosylase (FPG)-modified comet assay. In conclusion, activated PMNs induce frameshift mutations in colon epithelial cells resulting in MSI. Both oxidative burst with release of ROS and PMN-secreted cytokines, such as IL-8, IL-6 or TNF-α, contribute to MSI. ROS scavengers and/or specific inhibitors of cytokine signaling may delay or prevent cancer development in the setting of colitis.